THE Australian pharmaceutical industry continues to face significant headwinds, with a new report from consulting firm PricewaterhouseCoopers revealing the ongoing impact of PBS reforms and price disclosure.
n
Conducted in conjunction with Medicines Australia, the Issues and Decisions report is the outcome of a confidential survey of a wide cross- section of industry participants. Pharmacy Daily – Read More.